section name header

Footnotes

a Tested in PVC containers.

b Tested in PVC/Kalex 3000 (phthalate ester) CADD pump reservoirs.

c Tested in non-DEHP containers.

d Tested in portable infusion pump reservoirs (Pharmacia Deltec).

e Drug powder dissolved in ziconotide acetate injection.

f Tested in SynchroMed II implantable pumps.

g Tested with fentanyl citrate (JN) 1.25 mg.

h Tested with fentanyl citrate (IVX) 2 mg.

i Tested with fentanyl citrate (JN) 35 mg.

j Tested with clonidine HCl (BI) 9 mg.

k Tested with epinephrine HCl (AB) 0.69 mg.

l Tested with epinephrine bitartrate 2 mg.

m Bitartrate salt of epinephrine tested.

n Extemporaneously compounded.

o Tested in Codman 3000 implantable pumps and glass containers.

p Tested with morphine sulfate (extemporaneously compounded) 50 g/L.

q Tested with hydromorphone HCl (extemporaneously compounded) 50 g/L.

r Tested with clonidine HCl (extemporaneously compounded) 2 g/L.